ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Dompé’s Oxervate gets approval to treat neurotrophic keratitis in US
August 27, 2018Italian biopharmaceutical company Dompé farmaceutici has secured approval from the US Food and Drug Administration (FDA) for the use of its Oxervate medicine to treat neurotrophic keratitis. -
Dompé's Oxervate gains FDA approval as first drug treatment for neurotrophic keratitis
August 24, 2018The FDA announced the approval of Dompé Farmaceutici's topical eye drop Oxervate (cenegermin-bkbj) as the first drug treatment in the US for neurotrophic keratitis.
Pharma Sources Insight January 2025
